推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
一又友装修完透风三个月,入住的时间也曾有股滋味。 测了甲醛,达标。但那股说不清的
关于OD
不雅点网讯:5月21日,福州市台江区书记,将在2026年中国福州海外招商月行径技
关于OD
5月16日晚,昆山奥体中心,江苏足球超等联赛迎来精彩对决,苏州队镇守主场迎战连云
188金宝博官网app下载 5月16日晚,苏超苏州主场迎战连云港,上海戏校校长、
北京时刻5月20日凌晨1点,2026年谷歌I/O大会矜重演出,AI依旧是弥散的主
【【【序论:iQOO的数字系列旗舰,迎来了新成员】】】 无人不晓,在iQOO的旗

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
vasoactive intestinal peptide tumor相关文献:
Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.
Moody TW, Nuche-Berenguer B, Jensen RT.
Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):38-47. doi: 10.1097/MED.0000000000000218.
PMID:26702849
Vasoactive Intestinal Peptide-Secreting Tumors: A Review.
Siddappa PK, Vege SS.
Pancreas. 2019 Oct;48(9):1119-1125. doi: 10.1097/MPA.0000000000001402.
PMID:31609932
Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF.
Sallicandro L, Gliozheni E, Feudi D, Sabbatini P, Pellegrino RM, Alabed HBR, Baldini D, Gerli S, Alviggi C, Cascardi E, Cicinelli E, Malvasi A, Fioretti B.
Front Endocrinol (Lausanne). 2024 May 7;15:1331282. doi: 10.3389/fendo.2024.1331282. eCollection 2024.
PMID:38774232
Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice.
Kittikulsuth W, Nakano D, Kitada K, Uyama T, Ueda N, Asano E, Okano K, Matsuda Y, Nishiyama A.
Sci Rep. 2023 Jan 17;13(1):927. doi: 10.1038/s41598-023-28073-6.
PMID:36650220
Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization.
Li M, Xue Y, Chi L, Jin L.
Curr Protein Pept Sci. 2024;25(6):480-491. doi: 10.2174/0113892037287189240122110819.
PMID:38284716
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Ravindranathan S, Passang T, Li JM, Wang S, Dhamsania R, Ware MB, Zaidi MY, Zhu J, Cardenas M, Liu Y, Gumber S, Robinson B, Sen-Majumdar A, Zhang H, Chandrakasan S, Kissick H, Frey AB, Thomas SN, El-Rayes BF, Lesinski GB, Waller EK.
Nat Commun. 2022 Oct 27;13(1):6418. doi: 10.1038/s41467-022-34242-4.
PMID:36302761
[Vasoactive intestinal peptide-producing tumor (ViPoma)].
Doi R, Tsukada T.
Nihon Rinsho. 2006 Sep 28;Suppl 3:358-62.
PMID:17022564
Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.
Hara M, Takeba Y, Iiri T, Ohta Y, Ootaki M, Watanabe M, Watanabe D, Koizumi S, Otsubo T, Matsumoto N.
Cancer Sci. 2019 Jan;110(1):235-244. doi: 10.1111/cas.13861. Epub 2018 Dec 4.
PMID:30390393
Carcinoid heart findings in vasoactive intestinal peptide-secreting tumour.
Joshi M, Aldea D, Ngo P, Shah S.
BMJ Case Rep. 2024 Nov 7;17(11):e262229. doi: 10.1136/bcr-2024-262229.
PMID:39510606
Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.
Klippstein R, Pozo D.
Adv Protein Chem Struct Biol. 2015;98:145-68. doi: 10.1016/bs.apcsb.2014.11.006. Epub 2015 Mar 3.
PMID:25819279
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3